351 related articles for article (PubMed ID: 15056517)
1. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits.
Centorrino F; Goren JL; Hennen J; Salvatore P; Kelleher JP; Baldessarini RJ
Am J Psychiatry; 2004 Apr; 161(4):700-6. PubMed ID: 15056517
[TBL] [Abstract][Full Text] [Related]
2. Use of combinations of antipsychotics: McLean Hospital inpatients, 2002.
Centorrino F; Fogarty KV; Sani G; Salvatore P; Cincotta SL; Hennen J; Guzzetta F; Talamo A; Saadeh MG; Baldessarini RJ
Hum Psychopharmacol; 2005 Oct; 20(7):485-92. PubMed ID: 16116665
[TBL] [Abstract][Full Text] [Related]
3. Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004.
Centorrino F; Ventriglio A; Vincenti A; Talamo A; Baldessarini RJ
Hum Psychopharmacol; 2010 Mar; 25(2):179-86. PubMed ID: 20196186
[TBL] [Abstract][Full Text] [Related]
4. Hospital use of antipsychotic drugs: polytherapy.
Centorrino F; Cincotta SL; Talamo A; Fogarty KV; Guzzetta F; Saadeh MG; Salvatore P; Baldessarini RJ
Compr Psychiatry; 2008; 49(1):65-9. PubMed ID: 18063043
[TBL] [Abstract][Full Text] [Related]
5. Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore.
Sim K; Su A; Chan YH; Shinfuku N; Kua EH; Tan CH
Psychiatry Clin Neurosci; 2004 Jun; 58(3):324-9. PubMed ID: 15149301
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
[TBL] [Abstract][Full Text] [Related]
7. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
8. Audit of antipsychotic prescribing in a private psychiatric hospital.
Botvinik L; Ng C; Schweitzer I
Australas Psychiatry; 2004 Sep; 12(3):227-33. PubMed ID: 15715780
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M;
Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic polytherapy on an inpatient psychiatric unit: how does clinical practice coincide with Joint Commission guidelines?
Huffman JC; Chang TE; Durham LE; Weiss AP
Gen Hosp Psychiatry; 2011; 33(5):501-8. PubMed ID: 21762994
[TBL] [Abstract][Full Text] [Related]
11. Factors related to prescription dosage in Japanese psychiatric hospitals.
Nawata S; Yamauchi K; Ikegami N
Psychiatry Clin Neurosci; 2005 Feb; 59(1):70-6. PubMed ID: 15679543
[TBL] [Abstract][Full Text] [Related]
12. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy.
Gören JL; Beck SE; Mills BJ; Shtasel DL; Dufresne RL
J Manag Care Pharm; 2010; 16(6):393-401. PubMed ID: 20635830
[TBL] [Abstract][Full Text] [Related]
13. A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia.
Suzuki T; Uchida H; Watanabe K; Yagi G; Kashima H
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):361-9. PubMed ID: 14751434
[TBL] [Abstract][Full Text] [Related]
14. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic combination using low-dose antipsychotics is as efficacious and safe as, but cheaper, than optimal-dose monotherapy in the treatment of schizophrenia: a randomized, double-blind study.
Lin CH; Wang FC; Lin SC; Huang YH; Chen CC; Lane HY
Int Clin Psychopharmacol; 2013 Sep; 28(5):267-74. PubMed ID: 23778382
[TBL] [Abstract][Full Text] [Related]
16. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.
Broder MS; Bates JA; Jing Y; Hebden T; Forbes RA; Chang E
J Med Econ; 2012; 15(1):105-11. PubMed ID: 21991926
[TBL] [Abstract][Full Text] [Related]
17. Assessment of inpatient psychiatric readmission risk among patients discharged on an antipsychotic polypharmacy regimen: A retrospective cohort study.
Boskailo E; Malkoc A; McCurry DB; Venter J; Drachman D; Ramos GM
Acta Med Acad; 2017 Nov; 46(2):133-144. PubMed ID: 29338277
[TBL] [Abstract][Full Text] [Related]
18. Clinical practice variations in prescribing antipsychotics for patients with schizophrenia.
Owen RR; Fischer EP; Kirchner JE; Thrush CR; Williams DK; Cuffel BJ; Elliott CE; Booth BM
Am J Med Qual; 2003; 18(4):140-6. PubMed ID: 12934949
[TBL] [Abstract][Full Text] [Related]
19. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
